In the second part of this roundtable, Steven Horwitz, MD; Alison Moskowitz, MD; and Barbara Pro, MD, discuss the background, findings, and importance of the ECHELON-2 clinical trial.

In the first part of this roundtable, Steven Horwitz, MD; Alison Moskowitz, MD; and Barbara Pro, MD, discuss the challenges of treating patients with T-cell lymphoma.

Paolo Caimi, MD, discusses findings from a study examining the use of prophylactic tocilizumab prior to anti-CD19 CAR-T therapy for relapsed/refractory lymphoma.

Dr Bussel shares insight on hot topics, highlights, and key takeaways from this year's virtual event.

Dr Percival discusses the provision of care to patients with AML during the COVID-19 pandemic.

On this episode of Blood Bytes, John Leonard, MD, and Richard Furman, MD, discuss BTK inhibitors for the treatment of CLL and lymphomas.

Mary-Elizabeth Percival, MD, outlines considerations for treating patients with hematologic malignancies during the COVID-19 pandemic.

Mehdi Hamadani, MD, discusses the impact the global pandemic has had on bone marrow and stem cell transplantation for patients with blood cancers.